AQR Capital Management LLC Reduces Stock Position in Alignment Healthcare, Inc. $ALHC

Key Points

• AQR Capital Management LLC has reduced its stake in Alignment Healthcare, Inc. by 14.0%, now owning 297,323 shares, valued at approximately $5.5 million.
• CEO John E. Kao sold 355,018 shares at an average price of $16.41, decreasing his ownership by 7.26% and valuing his remaining shares at around $74.4 million.
• Alignment Healthcare's stock closed at $16.04, with recent quarterly earnings showing a significant revenue increase of 49.0% year-over-year, totaling $1.02 billion.

AQR Capital Management LLC lowered its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 14.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 297,323 shares of the company's stock after selling 48,491 shares during the quarter. AQR Capital Management LLC owned approximately 0.15% of Alignment Healthcare worth $5,536,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Northern Trust Corp boosted its position in shares of Alignment Healthcare by 8.6% during the 4th quarter. Northern Trust Corp now owns 908,964 shares of the company's stock valued at $10,226,000 after acquiring an additional 72,063 shares during the last quarter. Ameriprise Financial Inc. bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $14,155,000. BNP Paribas Financial Markets bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $234,000. Baird Financial Group Inc. bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $315,000. Finally, Balyasny Asset Management L.P. bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $542,000. Institutional investors own 86.19% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ALHC shares. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research note on Monday, August 25th. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Zacks Research raised Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $18.83.

Insider Buying and Selling at Alignment Healthcare

In other news, insider Christopher J. Joyce sold 30,939 shares of the business's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $507,708.99. Following the completion of the transaction, the insider directly owned 343,592 shares of the company's stock, valued at approximately $5,638,344.72. The trade was a 8.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Robert L. Scavo sold 29,535 shares of the business's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $484,669.35. Following the transaction, the insider owned 572,555 shares in the company, valued at approximately $9,395,627.55. This trade represents a 4.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,142,077 shares of company stock worth $18,068,259 over the last quarter. Insiders own 7.00% of the company's stock.

Alignment Healthcare Price Performance

NASDAQ ALHC traded down $0.20 during trading on Thursday, hitting $16.48. 7,884,244 shares of the stock traded hands, compared to its average volume of 3,782,422. The company has a market capitalization of $3.26 billion, a P/E ratio of -58.86 and a beta of 1.17. The firm has a 50-day simple moving average of $14.64 and a 200-day simple moving average of $15.57. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. Alignment Healthcare, Inc. has a 12-month low of $9.15 and a 12-month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company's revenue for the quarter was up 49.0% on a year-over-year basis. During the same period last year, the company earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.